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An exciting new study from Alanko et al. indicates that following cell 
detachment, endocytosed integrins can drive assembly of functional signalling 
complexes on the cytoplasmic face of endocytic membranes.  This keeps 
circulating cancer cells alive to increase their metastatic capacity.    
 
Many cell types rely on integrin-mediated contact with the extracellular matrix (ECM) 
for growth and survival.  Therefore, when anchorage-dependent cells become 
detached from the ECM they cease to thrive and begin to die via a form of 
programmed cell death called anoikis.  When cells are attached, integrins engage 
with the ECM and cluster at the plasma membrane to form large macromolecular 
signalling machines termed ‘focal adhesions’ or ‘focal contacts’.  The clustering of 
ligand-engaged integrins into focal adhesions promotes recruitment of signalling and 
cytoskeletal adaptor proteins, such as focal adhesion kinase (FAK) and talin 
respectively to integrin cytoplasmic domain (Fig. 1A).  These adaptors, in turn, 
mediate mechanical links to the actin cytoskeleton to allow force transmission, but 
also bring-in numerous signalling moieties that lead to activation of pathways which 
support cell growth and suppress anoikis. Prominent integrin-activated signalling 
pathways are the Ras-PI3K-PDK1-Akt and Ras-Raf-MEK-ERK axes and, although 
the mechanistic details of how integrin engagement leads to their activation are a 
little obscure, there is copious evidence that following cell detachment the activity of 
these pathways is reduced and this increases the likelihood of cells entering anoikis.  
To metastasise, cancer cells must leave their organ of origin and travel through the 
lymphatics and circulatory system to colonise other organs.  This entails loss of 
adhesive contact with the ECM and so, to complete this journey, cancer cells must 
develop mechanisms to circumnavigate anoikis.  One way in which cancer cells 
suppress anoikis is via the acquisition of activating mutations in anti-apoptotic 
pathways, such as the Ras-PI3K-PDK1-Akt axis, or by loss of tumour suppressors, 
such as PTEN.  This report from Alanko et al. indicates that there is another route to 
anoikis suppression that does not necessitate mutation-based activation of pro-
survival signalling pathways.  Alanko et al. have elegantly shown that following cell 
detachment integrins move from the cell surface to populate endosomes, and then 
remain in an active state within these compartments.  This allows integrins to recruit 
the signalling adaptor FAK and other focal adhesion proteins (such as talin and 
vinculin) to endosomal membranes which can then command anti-apoptotic 
signalling at this intracellular locale (Fig. 1B).  Importantly, the study goes on to show 
that this process may be linked to the acquisition of metastatic capacity in cancer.  
Indeed, Alanko et el. find that a Rab subfamily GTPase (Rab21), which drives 
actively-signalling integrins to endosomes, is required  for breast cancer cells to 
colonise the lung – an experiment that provides encouraging evidence that integrin 
endosomal signalling dictates metastatic potential in vivo.   
It is now well established that growth-factor receptors signal from endosomes in a 
way that influences anoikis. For instance, sorting nexin 1 (SNX1) has been shown to 
be downregulated during colon cancer progression, and this correlates with 
acquisition of anoikis resistance (1). Mechanistically, downregulation of SNX1 drives 
endocytosis-dependent activation of EGFR and MAPK pathway, leading to survival 
in absence of adhesion. More recently, Rab7 has been shown to promote EGFR/Akt 
signalling at late endosomes to sustain anchorage-independent growth in breast 
cancer cells (2).  However, none of these studies definitely link the loss of adhesion 
with anoikis resistance, nor do they explain how integrin signalling may be 
reprogrammed in response to cell detachment.   
Integrin endocytosis and recycling has been studied in some detail in the past few 
years and, in some cases, the way in which these processes influence signalling 
pathways to alter cell migration is well-described.  For instance, the Rab11 effector, 
RCP coordinates recycling of integrins with receptor tyrosine kinases (RTKs), to 
promote Akt-mediated  phosphorylation of RacGAP1 (3) (4) (5) (6).   Phosphorylated 
RacGAP1 then locally promotes RhoA activation at the tip of cellular protrusion, thus 
promoting invasiveness (4).  Furthermore, tensin and Arf4-dependent internalisation 
of ligand-HQJDJHGĮȕ LQWHJULQ WR ODWHHQGRVRPHV LVQHFHVVDU\ IRU UHFUXLWPHQWRI
mTOR to lysosomal membranes, providing a link between adhesion and nutrient 
signalling (7).  Despite these advances, there is very little known about how integrins 
traffic following detachment of cells that are normally adherent. Moreover, it has not 
been clear whether integrins can recruit adaptors to signal from endosomal 
membranes as has been shown to occur for RTKs.  Alanko et al.’s  findings 
convincingly show that this can indeed occur in a way that is physiologically and 
pathophysiologically relevant, and further demonstrate that focal adhesion adaptors 
previously thought to be recruited only to adhesion sites at the plasma membrane 
can physically interact with integrin cytodomains which are exposed on the 
cytoplasmic face of isolated endosomes.    
This description of integrin signalling at endosomal membranes provide a rationale 
for how cell detachment may help to suppress anoikis in cancer cells, and also 
poses a number of interesting questions for future research.  Prominent open 
questions are: given the established role of mechanical tension and receptor 
clustering in integrin signalling, how can this signalling be maintained within an 
endosome where there is no apparent means for force generation?  What dictates 
the contribution of ‘classic’ focal adhesion signalling versus integrin endosomal 
signalling, and which integrin-containing signalling platforms are specifically 
assembled on endosomes?  Lastly, we feel that it will be important to investigate this 
process in the context of mutations (such as those leading to constitutive activation 
of RTKs and their downstream signalling) that are already known to suppress 
anoikis, as this may provide indications as to whether strategies aimed at targeting 
endosomal integrins may be combined with existing anti-oncogenic signalling 
therapies to kill circulating cancer cells.   
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 Figure 1.  Integrins can drive assembly of pro-survival signalling complexes at 
the plasma membrane and at endosomes 
(A)  Integrins can cluster into focal adhesions at the plasma membrane to recruit and 
activate focal adhesion kinase (FAK) which promotes cell survival. 
(B)  Following detachment, Rab21 drives endocytosis of activated integrins and this 
leads to their accumulation within endosomes.  Internalised integrins then recruit 
active phosphorylated FAK to endosomal membranes to promote signalling to 
suppress anoikis.   
